These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 5561835)

  • 1. Drug abuse treatment programs. Discussion summary.
    Hospitals; 1971 Aug; 45(15):56-9. PubMed ID: 5561835
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug abuse programs: are hospitals too late and too square?
    Philips DF
    Hospitals; 1971 Jan; 45(2):55-60. PubMed ID: 5123315
    [No Abstract]   [Full Text] [Related]  

  • 3. The hospital and drug abuse treatment programs.
    Hospitals; 1971 Aug; 45(15):39. PubMed ID: 5561829
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of drug addicts in the USA and deliberations concerning treatment of drug addicts in Copenhagen].
    Groth A
    Ugeskr Laeger; 1972 May; 134(21):1119-30. PubMed ID: 5045780
    [No Abstract]   [Full Text] [Related]  

  • 5. A cost-effectiveness model for evaluating health care programs: application to drug abuse treatment.
    Goldschmidt PG
    Inquiry; 1976 Mar; 13(1):29-47. PubMed ID: 130347
    [No Abstract]   [Full Text] [Related]  

  • 6. Hospitals coordinate chemical abuse programs.
    Malloy JM
    Hospitals; 1974 Oct; 48(20):59-62. PubMed ID: 4413701
    [No Abstract]   [Full Text] [Related]  

  • 7. Health-hospital approach to drug abuse.
    Wadler GI; McCartney JR; Buckley DF; Imhof JE
    N Y State J Med; 1972 May; 72(10):1194-8. PubMed ID: 4504722
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug abuse treatment programs. An emerging federal role.
    Miller DE
    Hospitals; 1971 Aug; 45(15):50-2 passim. PubMed ID: 5561833
    [No Abstract]   [Full Text] [Related]  

  • 9. Behavioral intervention techniques in drug abuse treatment: summary of discussion.
    Stitzer ML; Grabowski J; Henningfield JE
    NIDA Res Monogr; 1984; 46():147-57. PubMed ID: 6427621
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is conventional wisdom wrong? Coverage for substance abuse treatment under Medicaid managed care.
    Maglione M; Ridgely MS
    J Subst Abuse Treat; 2006 Jun; 30(4):285-90. PubMed ID: 16716842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug abuse: treatment programs in hospitals.
    Barton WI
    Hospitals; 1974 Jul; 48(14):42-6. PubMed ID: 4837755
    [No Abstract]   [Full Text] [Related]  

  • 13. Tuberculosis treatment through directly observed therapy in a large multisite methadone maintenance treatment program: addressing the public health needs of a high-risk population.
    Altarac D; Dansky SF
    J Public Health Manag Pract; 1995; 1(4):40-7. PubMed ID: 10186640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A profile of the substance abuse treatment industry: organization, costs, and treatment completion.
    Woodward AM; Raskin IE; Blacklow B
    Subst Use Misuse; 2008; 43(5):647-79. PubMed ID: 18393082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A county health department's role in drug programs.
    Morton FL
    HSMHA Health Rep; 1971 Dec; 86(12):1069-76. PubMed ID: 5157794
    [No Abstract]   [Full Text] [Related]  

  • 16. [Results in treatment of narcotic drug addicts].
    Koran LN
    Bull Soc Sci Med Grand Duche Luxemb; 1972 Mar; 109(1):77-81. PubMed ID: 5056100
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of organization and management in substance abuse treatment: Review and roadmap.
    D'Aunno T
    J Subst Abuse Treat; 2006 Oct; 31(3):221-33. PubMed ID: 16996385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nature and status of drug abuse treatment.
    Nurco DN; Kinlock TW; Hanlon TE
    Md Med J; 1994 Jan; 43(1):51-7. PubMed ID: 8183085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Locations of facilities with special programs for older substance abuse clients in the US.
    Schultz SK; Arndt S; Liesveld J
    Int J Geriatr Psychiatry; 2003 Sep; 18(9):839-43. PubMed ID: 12949852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.